Products for Research Use Only
RegisterLogin

Lifastuzumab vedotin

CAT: 0957-D4010-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-D4010-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lifastuzumab vedotin (LIFA, DNIB0600A, RG-7599) is an antibody-drug conjugate (ADC) composed of a humanized anti-NaPi2b monoclonal antibody and an anti-mitotic cytotoxic agent, monomethyl auristatin E (MMAE) . Lifastuzumab vedotin is used in the treatment of platinum-resistant ovarian cancer.
CAS Number
2485779-13-1
Synonyms
LIFA, DNIB0600A, RG-7599
Target
Sodium Channel
Activity
Transmembrane Transporters
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Related Products

CatalogName
A2350-1mg*5Lifastuzumab (Anti-SLC34A2)
A2350-01Lifastuzumab (Anti-SLC34A2)
A2350-1mg*25Lifastuzumab (Anti-SLC34A2)
A2350-1mgLifastuzumab (Anti-SLC34A2)
D4045-01Brentuximab vedotin
D4013-01Zilovertamab vedotin
D4051-1mgTisotumab vedotin
D4045-1mgBrentuximab vedotin
D4038-1mg*5Enapotamab vedotin
D4019-1mgSirtratumab vedotin

Alternative Products

CatalogName
HY-P99705-01Lifastuzumab vedotin
DHB65499Lifastuzumab vedotin (ADC)
591970Lifastuzumab Vedotin (SLC34A2)
GTR18401363-01Lifastuzumab vedotin Antibody
C00852-1mg*25Lifastuzumab vedotin (Anti-SLC34A2)
F1439-5Anti-NaPi2b/SLC34A2 Antibody (Lifastuzumab vedotin)
10-628Lifastuzumab Vedotin (SLC34A2) - Research Grade Biosimilar
GTR18315576NaPi2b / SLC34A2 Reference Antibody (lifastuzumab vedotin)
GTR18117460Lifastuzumab Vedotin (SLC34A2) - Research Grade Biosimilar Antibody
MBS9247242-01Anti-NaPi2b/SLC34A2 Reference Antibody (lifastuzumab vedotin)

Popular Products